06.06.2026
... BB Biotech -3,32%, Sartorius -3,43%, Roche GS -3,85%, Gilead Sciences -3,92 ... 43% , Evotec -7,64% , Epigenomics -8,58% , Roche GS -10,47% , Lanxess -12 ...
06.06.2026
... %, voestalpine -2,48%, Alphabet -2,83%, Roche GS -3,85%, IBM -4,35%, Volkswagen ... % , Intel -8,3% , Amazon -10,06% , Roche GS -10,47% und GlaxoSmithKline ...
01.06.2026
... -Technologien, die letztlich zur Genentech/Roche-Therapie KADCYLA® beitrugen, die 2013 ...
30.05.2026
... -2,09%, Merck Co. -3,01%, Roche GS -3,85%, Bayer -5,14%, Fresenius ... 65% , Lanxess -8,33% , Epigenomics -8,58% , Roche GS -10,47% , Fresenius -11 ...
30.05.2026
... -2,07%, Johnson & Johnson -3,84%, Roche GS -3,85%, Intel -4,31% und ... , Toyota Motor Corp. -2,1% , Sanofi -4,56% , Roche GS -10,47% und GlaxoSmithKline ...
23.05.2026
... BB Biotech -1,23%, BASF -1,82%, Roche GS -3,85%, Epigenomics -6,99%, Lanxess ... , Epigenomics -8,58% , Fresenius -10,38% , Roche GS -10,47% , Medigene -12 ...
23.05.2026
... Corp. -2,13%, Alphabet -3,54%, Roche GS -3,85% und GlaxoSmithKline -19 ... , Pfizer -5,16% , Toyota Motor Corp. -7% , Roche GS -10,47% und GlaxoSmithKline ...